Fetal renal failure after intrauterine exposure to inhibitors of the renin-angiotensin system;Fetale Niereninsuffizienz bei Therapie mit Hemmstoffen des Renin-Angiotensin-Systems in der Schwangerschaft

Deutsche Medizinische Wochenschrift

Volumn 137, Issue 24, 2012, Pages 1297-1300

  Markfeld Erol, F ^a   Farthmann, J ^a   Prompeler H ^a   Kunze, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

arterial hypertension; medication; pregnancy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLDOPA;

ADULT; AMNION FLUID; ARTICLE; BLOOD PRESSURE; CASE REPORT; CHRONIC KIDNEY FAILURE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; MATERNAL HYPERTENSION; OLIGOHYDRAMNIOS; PREMATURE FETUS MEMBRANE RUPTURE; PRENATAL DRUG EXPOSURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANTIHYPERTENSIVE AGENTS; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; FETAL DISEASES; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; MALE; OLIGOHYDRAMNIOS; PREGNANCY;

EID: 84861774883     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1305063     Document Type: Article

References (11)

1. Alwan S, Polifka J, Friedman JM. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol: 2005; 73 123 130 (Pubitemid 40289535)
2. Chesley LC. The control of hypertension in pregnancy. Obstet Gynecol Annu: 1981; 10 69 106 (Pubitemid 12194815)
3. Cooper W et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med: 2006; 8 354: 2443 2451
4. Cífková R. Hypertension in pregnancy: recommendations for diagnosis and treatment. J Hypertens: 2000; 18 1346 1348
5. Deutsche Gesellschaft für Hypertonie und Prävention - Deutsche Hochdruckliga e.V. (DHL) Schwangerschaft und Stillzeit. In: Leitlinien zur Behandlung der arteriellen Hypertonie. Heidelberg: 2008; 69 75 www.awmf-online.de (letzter Zugriff am 15.5.2012)
6. Dubois D et al. Treatment of hypertension in pregnancy with beta adrenoceptor antagonists. Br J Clin Pharmacol: 1982; 13 02 375S 378S (Pubitemid 13144823)
7. Gallery ED, Ross MR, Gyory AZ. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. Br Med J (Clin Res Ed): 1985; 291 563 566 (Pubitemid 15225457)
8. Rath W et al. Leitlinien der Arbeitsgemeinschaft Schwangerschaftshochdruck/Gestose der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG): Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen,. Mai 2008. www.awmf.org (letzter Zugriff am 15.5.2012)
9. Schaefer C. Angiotensin II-receptor antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res a Clin Mol Teratol: 2003; 67 591 594 (Pubitemid 37247675)
10. Seely EW, Ecker J. Chronic hypertension in pregnancy. N Engl J Med: 2011; 365 439 446
11. Velázquez-Armenta E et al. Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature. Hypertens Pregnancy: 2007; 26 51 66 (Pubitemid 46649346)